- Home
- SUPN vs GDYN Comparison
SUPN vs GDYN Comparison
Compare SUPN & GDYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- GDYN
- Stock Information
- Founded
- SUPN 2005
- GDYN 2006
- Country
- SUPN United States
- GDYN United States
- Employees
- SUPN N/A
- GDYN N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- GDYN Computer Software: Prepackaged Software
- Sector
- SUPN Health Care
- GDYN Technology
- Exchange
- SUPN Nasdaq
- GDYN Nasdaq
- Market Cap
- SUPN 2.1B
- GDYN 1.9B
- IPO Year
- SUPN 2012
- GDYN N/A
- Fundamental
- Price
- SUPN $33.05
- GDYN $21.37
- Analyst Decision
- SUPN Hold
- GDYN Strong Buy
- Analyst Count
- SUPN 2
- GDYN 7
- Target Price
- SUPN $36.00
- GDYN $18.86
- AVG Volume (30 Days)
- SUPN 464.2K
- GDYN 766.7K
- Earning Date
- SUPN 02-25-2025
- GDYN 02-20-2025
- Dividend Yield
- SUPN N/A
- GDYN N/A
- EPS Growth
- SUPN 130.79
- GDYN N/A
- EPS
- SUPN 1.07
- GDYN 0.05
- Revenue
- SUPN $651,972,000.00
- GDYN $350,571,000.00
- Revenue This Year
- SUPN $7.94
- GDYN $12.94
- Revenue Next Year
- SUPN N/A
- GDYN $18.16
- P/E Ratio
- SUPN $31.70
- GDYN $427.40
- Revenue Growth
- SUPN 6.79
- GDYN 12.04
- 52 Week Low
- SUPN $25.53
- GDYN $9.07
- 52 Week High
- SUPN $40.28
- GDYN $25.50
- Technical
- Relative Strength Index (RSI)
- SUPN 32.98
- GDYN 45.54
- Support Level
- SUPN $32.53
- GDYN $20.40
- Resistance Level
- SUPN $39.99
- GDYN $24.60
- Average True Range (ATR)
- SUPN 1.31
- GDYN 1.17
- MACD
- SUPN -0.69
- GDYN -0.33
- Stochastic Oscillator
- SUPN 6.71
- GDYN 19.02
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc provides enterprise-level digital transformation in the areas of search, analytics, and release automation to Fortune 1000 companies. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.